These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29794338)

  • 1. Tumor-on-a-chip platforms for assessing nanoparticle-based cancer therapy.
    Wang Y; Cuzzucoli F; Escobar A; Lu S; Liang L; Wang S
    Nanotechnology; 2018 Aug; 29(33):332001. PubMed ID: 29794338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles for thermal cancer therapy.
    Day ES; Morton JG; West JL
    J Biomech Eng; 2009 Jul; 131(7):074001. PubMed ID: 19640133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ-on-chip systems as a model for nanomedicine.
    Stavrou M; Phung N; Grimm J; Andreou C
    Nanoscale; 2023 Jun; 15(23):9927-9940. PubMed ID: 37254663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mini-pillar array for hydrogel-supported 3D culture and high-content histologic analysis of human tumor spheroids.
    Kang J; Lee DW; Hwang HJ; Yeon SE; Lee MY; Kuh HJ
    Lab Chip; 2016 Jun; 16(12):2265-76. PubMed ID: 27194205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced biomedical applications based on emerging 3D cell culturing platforms.
    Wang A; Madden LA; Paunov VN
    J Mater Chem B; 2020 Dec; 8(46):10487-10501. PubMed ID: 33136103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable Hydrogels as Unique Platforms for Local Chemotherapeutics-Based Combination Antitumor Therapy.
    Yu S; He C; Chen X
    Macromol Biosci; 2018 Dec; 18(12):e1800240. PubMed ID: 30303620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles for cancer therapy using magnetic forces.
    Tietze R; Lyer S; Dürr S; Alexiou C
    Nanomedicine (Lond); 2012 Mar; 7(3):447-57. PubMed ID: 22385201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black hollow silicon oxide nanoparticles as highly efficient photothermal agents in the second near-infrared window for in vivo cancer therapy.
    Yu X; Yang K; Chen X; Li W
    Biomaterials; 2017 Oct; 143():120-129. PubMed ID: 28787664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of magnetic nanoparticles for hyperthermia.
    Thiesen B; Jordan A
    Int J Hyperthermia; 2008 Sep; 24(6):467-74. PubMed ID: 18608593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening.
    Castro F; Leite Pereira C; Helena Macedo M; Almeida A; José Silveira M; Dias S; Patrícia Cardoso A; José Oliveira M; Sarmento B
    Adv Drug Deliv Rev; 2021 Aug; 175():113824. PubMed ID: 34090966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the relevance of 3D cancer models in nanomedicine research.
    Leong DT; Ng KW
    Adv Drug Deliv Rev; 2014 Dec; 79-80():95-106. PubMed ID: 24996135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in cancer modeling: fluidic systems for increasing representativeness of large 3D multicellular spheroids.
    Piccinini F; Santis I; Bevilacqua A
    Biotechniques; 2018 Dec; 65(6):312-314. PubMed ID: 30477324
    [No Abstract]   [Full Text] [Related]  

  • 15. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
    Shi J; Xiao Z; Kamaly N; Farokhzad OC
    Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer decorated gold nanoparticles in nanomedicine conjugates.
    Capek I
    Adv Colloid Interface Sci; 2017 Nov; 249():386-399. PubMed ID: 28259207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-on-a-chip systems at the frontier of nanomedicine.
    Zhang YS; Zhang YN; Zhang W
    Drug Discov Today; 2017 Sep; 22(9):1392-1399. PubMed ID: 28390929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine.
    Carvalho MR; Barata D; Teixeira LM; Giselbrecht S; Reis RL; Oliveira JM; Truckenmüller R; Habibovic P
    Sci Adv; 2019 May; 5(5):eaaw1317. PubMed ID: 31131324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor immunity by magnetic nanoparticle-mediated hyperthermia.
    Kobayashi T; Kakimi K; Nakayama E; Jimbow K
    Nanomedicine (Lond); 2014 Aug; 9(11):1715-26. PubMed ID: 25321171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening.
    Millard M; Yakavets I; Zorin V; Kulmukhamedova A; Marchal S; Bezdetnaya L
    Int J Nanomedicine; 2017; 12():7993-8007. PubMed ID: 29184400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.